1Wiviott SD,Braunwald E,McCabe Ch,et al.Prasugrel versus clopidogrel in patients with acute coronary syndromes[J].N Engl J Med,2007,357(20):2001-2015.
2Van′t Hof AW,Ten Berg J,Heestermans T,et al.Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2):a multicentre,double-blind,randomised controlled trial[J].Lancet,2008,372(9638):537-546.
3Ndrepepa G,Schulz S,Keta D,et al.Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality[J].Am J Cardiol,2010,105(2):163-167.
4Chen T,Lam S.Rivaroxaban:an oral direct factor Xa inhibitor for the prevention of thromboembolism[J].Cardiol Rev,2009,17(4):192-197.
5Connolly SJ,Ezekowitz MD,Yusuf S,et al.Dabigatran versus warfarin in patients with atrial fibrillation[J].N Engl J Med,2009,361(12):1139-1151.
6Ridker PM,MacFadyen JG,Fonseca FA,et al.Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein:justification for the use of statins in prevention:an intervention trial evaluating rosuvastatin (JUPITER)[J].Circ Cardiovasc Qual Outcomes,2009,2(6):616-623.
10Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology[J]. Eur.Heart J, 2008,29(23):2909-2945.
